ORIC - ORIC Pharmaceuticals Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-10)
Last
 10.56		 Change
 ⇓ -0.15   (-1.40%)		 Volume
  941,003
Open
 10.72		 High
 11.08		 Low
 10.39
8EMA (Daily)
 10.66		 40EMA (Daily)
 10.53		 50EMA (Daily)
 10.55		 STO (Daily)
 22.672		 MACD Hist (Daily)
 -0.177
8EMA (Weekly)
 10.478		 40EMA (Weekly)
 10.25		 50EMA (Weekly)
 10.09		 STO (Weekly)
 54.428		 MACD Hist (Weekly)
 0.048
Company Profile
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com